Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy

Published:2024-08 Issue:8 Volume:27 Page:110465
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Louie Bryan H.^ORCID,Kato Shumei,Lim Jordan S.,Kim Ki Hwan,Lim Hyo Jeong,Okamura Ryosuke,Lee Suzanna,Kim Lisa,Sicklick Jason K.,Lippman Scott M.,Kurzrock Razelle

Funder

National Cancer Institute

Publisher

Elsevier BV

Reference29 articles.

1. The burden of rare cancers in the United States;DeSantis;CA. Cancer J. Clin.,2017

2. Targeted therapy in rare cancers--adopting the orphans;Munoz;Nat. Rev. Clin. Oncol.,2012

3. Ultra-Rare Sarcomas: A Consensus Paper From the Connective Tissue Oncology Society Community of Experts on the Incidence Threshold and the List of Entities;Stacchiotti;Cancer,2021

4. The value of research collaborations and consortia in rare cancers;Blay;Lancet Oncol.,2016

5. The promise and challenges of rare cancer research;Komatsubara;Lancet Oncol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP